everolimus

• 

Nivolumab associated with improved quality of life versus everolimus

By Sharon Kell|2016-06-14T16:53:04+00:0014 Jun 2016|Drug treatments|

Data presented at the American Society of Clinical Oncology (ASCO) [...]

Read More

Comments Off on Nivolumab associated with improved quality of life versus everolimus

• 

Lenvatinib plus everolimus improves progression-free survival in renal cell carcinoma

By Sharon Kell|2016-06-14T16:19:45+00:0014 Jun 2016|Drug treatments|

Data presented at the American Society of Clinical Oncology (ASCO) annual [...]

Read More

Comments Off on Lenvatinib plus everolimus improves progression-free survival in renal cell carcinoma

• 

Cabozantinib extends survival in advanced kidney cancer compared to axitinib

By Sharon Kell|2016-06-14T14:25:04+00:0014 Jun 2016|Drug treatments|

Results from the phase III METEOR clinical trial, which compares [...]

Read More

Comments Off on Cabozantinib extends survival in advanced kidney cancer compared to axitinib

• 

FDA approves lenvatinib/everolimus combination for kidney cancer

By Sharon Kell|2016-05-16T12:09:46+00:0016 May 2016|Drug treatments|

The FDA has approved the combination of lenvatinib (Lenvima) and [...]

Read More

Comments Off on FDA approves lenvatinib/everolimus combination for kidney cancer

Sunitinib vs everolimus for advanced non-clear cell kidney cancer

By Sharon Kell|2016-05-09T08:58:03+00:009 May 2016|Drug treatments|

In a recent study published in the journal Lancet Oncology, [...]

Read More

Comments Off on Sunitinib vs everolimus for advanced non-clear cell kidney cancer